InsiderClue
Insiders · Profile

Schuchart Aaron

Chief Business Officer at Spyre Therapeutics. Filing since 27 Sep 2018. CIK 0001709258

Company
Date
Role
Action
Shares
Amount
Of holding
SYRE Spyre Therapeutics, Inc.
27 Sep 2018
Chief Business Officer
Sold, plan not stated
6,000
$57.01K
70.6%
1 decision on file.